相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Ningni Jiang et al.
MOLECULAR BIOLOGY REPORTS (2020)
PTEN Protein Loss and Loss-of-Function Mutations in Gastric Cancers: The Relationship with Microsatellite Instability, EBV, HER2, and PD-L1 Expression
Binnari Kim et al.
CANCERS (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang et al.
MOLECULAR CANCER (2019)
Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts
Luke Jones et al.
PEDIATRIC BLOOD & CANCER (2019)
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
Jo Lynne Rokita et al.
CELL REPORTS (2019)
Targeting PI3K Signaling in Acute Lymphoblastic Leukemia
Vanessa Edna Sanchez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases
Daniel A. Rodrigues et al.
PHARMACEUTICALS (2019)
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia
Cecilia Evangelisti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies
Kerrie Faia et al.
PLOS ONE (2018)
Toward the potential cure of leukemias in the next decade
Hagop M. Kantarjian et al.
CANCER (2018)
Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia
Sarah K. Tasian et al.
BLOOD (2017)
Mutations in the adaptor-binding domain and associated linker region of p110δ cause Activated PI3K-δ Syndrome 1 (APDS1)
Lucie Heurtier et al.
HAEMATOLOGICA (2017)
Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD
T. Yuan et al.
LEUKEMIA (2017)
Mutations in the adaptor-binding domain and associated linker region of p110δ cause Activated PI3K-δ Syndrome 1 (APDS1)
Lucie Heurtier et al.
HAEMATOLOGICA (2017)
Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis
Brendan Murphy et al.
CANCER RESEARCH (2016)
Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors
Patricia Mucci LoRusso
JOURNAL OF CLINICAL ONCOLOGY (2016)
Structural mutation analysis of PTEN and its genotype-phenotype correlations in endometriosis and cancer
Iris N. Smith et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2016)
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL
K. Balakrishnan et al.
LEUKEMIA (2015)
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
Lauren M. Thorpe et al.
NATURE REVIEWS CANCER (2015)
Role of integrin alpha4 in drug resistance of leukemia
Stephanie Shishido et al.
FRONTIERS IN ONCOLOGY (2014)
Targeting PI3K/Akt/mTOR signaling in cancer
Camillo Porta et al.
FRONTIERS IN ONCOLOGY (2014)
Two Birds with One Stone: Dual p110δ and p110γ Inhibition
Klaus Okkenhaug
CHEMISTRY & BIOLOGY (2013)
PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models
David G. Winkler et al.
CHEMISTRY & BIOLOGY (2013)
The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia
Roel Polak et al.
BLOOD (2012)
Glucocorticoid use in acute lymphoblastic leukaemia
Hiroto Inaba et al.
LANCET ONCOLOGY (2010)
The pediatric preclinical testing program: Description of models and early testing results
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2007)
Cutting edge:: Differential roles for phosphoinositide 3-kinases, p110γ and p110δ, in lymphocyte chemotaxis and homing
K Reif et al.
JOURNAL OF IMMUNOLOGY (2004)
Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies
NLM Liem et al.
BLOOD (2004)
分享论文
